TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Inro Biomedtek AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 36 | 36 | 36 |
Financial expenses | 701 | 0 | 46 |
Earnings before taxes | -663 | 340 | 1,900 |
EBITDA | 28 | 27 | 19 |
Total assets | 1,314 | 2,322 | 5,692 |
Current assets | 1,296 | 2,298 | 4,860 |
Current liabilities | 118 | 170 | 3,790 |
Equity capital | 1,196 | 2,065 | 1,830 |
- share capital | 9 | 10 | 10 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 91.0% | 88.9% | 32.2% |
Turnover per employee | 36 | 36 | 36 |
Profit as a percentage of turnover | -1841.7% | 944.4% | 5277.8% |
Return on assets (ROA) | 2.9% | 14.6% | 34.2% |
Current ratio | 1098.3% | 1351.8% | 128.2% |
Return on equity (ROE) | -55.4% | 16.5% | 103.8% |
Change turnover | 3 | 1 | -15 |
Change turnover % | 8% | 2% | -29% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.